In mammary carcinoma-bearing transgenic PyMT mice, CSF-1 was upregulated after exposure to paclitaxel, which was believed to contribute to the recruitment of macrophages to the tumor; combined αCSF-1 and paclitaxel significantly delayed tumor growth 4. This evidence concerns the gene CSF1 and breast carcinoma.